Liu et al. recently found that STING signaling in CD11c+ dendritic cells is required for the anti-tumor effects of CD47 blockade therapy and that tumor cells clearance by CD47 blockade is dependent on the recognition of tumor cells cytoplasmic DNA. Here, ITGAX is linked to neoplasm.